John H Lambert

Address:

6300 Stevenson Ave APT 702, Alexandria, VA 22304

Phone:

(703)3706833

VIN:

2HGFG12877H522887

Make:

HONDA

Model:

CIVIC

Year:

2007

US Patent:

6344563, Feb 5, 2002

Filed:

Jun 29, 2000

Appl. No.:

09/606609

Inventors:

Timothy Norris - Gales Ferry CT 06335
Megan E. Hnatow - Charlestown MA 02129
John F. Lambert - North Stonington CT 06359

International Classification:

C07D23356

US Classification:

5483111

Abstract:

process is described for preparing a compound of Formula (1. 3. 0): comprising: establishing a reaction mixture consisting of in an aprotic solvent; in the presence of a strong base in solid form selected from the group consisting of sodium hydroxide, NaOH; and potassium hydroxide, KOH;âand optionallyâin the presence of a catalytic amount of cesium carbonate, Cs CO , or of a phase transfer catalyst, especially a quaternary ammonium salt or a phosphonium saltâfollowed byâheating said reaction mixture under a nitrogen atmosphere; whereby there is produced a compound of Formula (1. 3. 0); and in a preferred embodiment the aprotic solvent is DMSO, the strong base in solid form is NaOH in powder or pellet form, and the phase transfer catalyst is tetra-n-butylammonium chloride (TBAC), which is used to prepare a preferred compound, useful as a 5-lipoxygenase inhibitor, of the formula: especially the substantially pure methanesulfonate salt thereof.

US Patent:

6346624, Feb 12, 2002

Filed:

Jun 29, 2000

Appl. No.:

09/607011

Inventors:

Timothy Norris - Gales Ferry CT
Megan E. Hnatow - Charlestown MA
John F. Lambert - North Stonington CT

Assignee:

Pfizer Inc - New York NY

International Classification:

C07D23360

US Classification:

5483111

Abstract:

A novel process intermediate, tetrahydro-4-[3-(4-fluorophenyl)thio]phenyl-2H-pyran-4-carboxamide, of the formula: is described, as well as its use in a process of preparing 5-lipoxygenase inhibitors of the formula: which comprises establishing a reaction mixture consisting of: and an electron deficient monocyclic or benzo-fused bicyclic N-heterocycle containing two nitrogen atoms of the formula: âin an aprotic solvent; in the presence of a carbonate of the formula: (M) -CO , where M is an alkali metal, Group 1/Ia element, selected from the group consisting of lithium, Li; sodium,Na; potassium, K; rubidium, Rb; and cesium, Cs; followed by heating of said reaction mixture under a nitrogen atmosphere; whereby there is produced the desired compound of the above-recited formula.

US Patent:

6753334, Jun 22, 2004

Filed:

Nov 27, 2001

Appl. No.:

09/995133

Inventors:

John F. Lambert - North Stonington CT
Timothy Norris - Gales Ferry CT

Assignee:

Pfizer, Inc. - New York NY
Pfizer Products, Inc. - Groton CT

International Classification:

C07D21538

US Classification:

514314, 546167, 546171

Abstract:

This invention relates to methods of preparing sodium-hydrogen exchanger type 1 (NHE-1) inhibitors of formula Iâ intermediates of the NHE-1 inhibitors and a new almost colorless form of the NHE-1 inhibitor N-(5-cyclopropyl-1-quinolin-5-yl-1H-pyrazole-4-carbonyl)-guanidine.

US Patent:

8559971, Oct 15, 2013

Filed:

Apr 5, 2011

Appl. No.:

13/080229

Inventors:

Michael A. Garcia - Herndon VA, US
Robert Mueller - Herndon VA, US
John W. Lambert - Herndon VA, US
John M. Dolan - Herndon VA, US

Assignee:

Exelis, Inc. - McLean VA

International Classification:

H04W 64/00
H04W 4/02
H04L 29/08

US Classification:

4554561, 340 81, 342387

Abstract:

A technique for determining the position of a mobile device includes receiving at the mobile device a set of time-slotted messages from a respective set of reference devices. Each of the time-slotted messages contains a slot ID indicating the assigned time slot in which it was broadcast. The slot ID is used to determine the time of transmission of each of the time-slotted messages received at the mobile device, and the position of the mobile device is determined via multi-lateration based on the time of flight of the time-slotted messages and known positions of the reference devices. According to another approach, the mobile device receives a set of ADS-B messages from a respective set of SBS ground stations. The time of transmission of each of the ADS-B messages is supplied in the ADS-B message itself or in a subsequent message and used to determined the position of the mobile device.

US Patent:

20120262339, Oct 18, 2012

Filed:

Apr 15, 2011

Appl. No.:

13/087809

Inventors:

Michael A. Garcia - Herndon VA, US
Robert Mueller - Herndon VA, US
John W. Lambert - Herndon VA, US
John M. Dolan - Herndon VA, US

Assignee:

ITT MANUFACTURING ENTERPRISES, INC. - Wilmington DE

International Classification:

G01S 1/24

US Classification:

342387

Abstract:

A technique for determining the position of a mobile device includes receiving messages from respective mobile reference devices. Each of the messages is broadcast beginning at one of several predetermined message start opportunity (MSO) times that have known timings relative to a reference time. Each of the messages contains a MSO value identifying the MSO time at which transmission of the message started. The MSO value is used to determine the time of transmission of each of the messages received at the mobile device, and the position of the mobile device is determined via multi-lateration. According to another approach, the mobile device receives a set of ADS-B messages from a respective set of mobile reference devices. The time of transmission of each of the ADS-B messages is supplied in the ADS-B message itself or in a subsequent message and used to determine the position of the mobile device.

US Patent:

44216394, Dec 20, 1983

Filed:

Jul 27, 1982

Appl. No.:

6/402447

Inventors:

John S. Lambert - New Providence NJ
Joseph W. Gleitsmann - late of Springfield NJ

Assignee:

Foster Wheeler Energy Corporation - Livingston NJ

International Classification:

C10G 2100
C10G 2128

US Classification:

208309

Abstract:

The invention is an energy-efficient improvement in a continuous deasphalting process in which a mixture of viscous hydrocarbon oils with resins and/or asphaltenes is contacted with a quantity of pure or mixed hydrocarbon solvents including, but not limited to, propane, butane, pentane, hexane, heptane, isomers thereof, and unsaturated hydrocarbons of similar molecular weights, in order to separate a primary extract phase comprising high viscosity oil, resins and/or asphaltenes, and solvent. The primary raffinate phase is further contacted with an additional quantity of solvent comprising similar components to those in the primary solvent (but not necessarily identical thereto) to separate a secondary extract phase comprising high viscosity oil and solvent, and a secondary raffinate phase comprising resins and/or asphaltenes and solvent. The contacting step may be repeated as often as desired to make additional extract phases which are recovered separately. The solvents from the extract and raffinate phases are separated from the associated viscous oils, resins and/or asphaltenes, and reused in the contacting process.

US Patent:

59359609, Aug 10, 1999

Filed:

Feb 7, 1997

Appl. No.:

8/798395

Inventors:

Stanley W. Walinsky - Mystic CT
John F. Lambert - Stonington CT

Assignee:

Pfizer Inc. - New York NY

International Classification:

A61K 31495
C07D40306

US Classification:

514253

Abstract:

The present invention relates to a pro-drug of ziprasidone or pharmaceutically acceptable salts thereof, processes for its preparation, and pharmaceutical compositions and methods of treatment comprising said pro-drug.

US Patent:

56060416, Feb 25, 1997

Filed:

Dec 20, 1994

Appl. No.:

8/351472

Inventors:

Frank R. Busch - Gales Ferry CT
Kathleen D. Goggin - Colchester CT
John F. Lambert - North Stonington CT
Russell J. Shine - Waterford CT
Stanley W. Walinsky - Mystic CT

Assignee:

Pfizer Inc. - New York NY

International Classification:

C07G 300
C07H 1500
C07J 900

US Classification:

536 185

Abstract:

Processes for the synthesis of tigogenin beta-O-cellobioside heptaalkanoate which is an intermediate for the known hypo-cholesterolemic agent tigogenin beta-cellobioside. The process comprises reacting. alpha. -cellobiosyl bromide heptaalkanoate and. beta. -tigogenin in the presence of zinc fluoride or zinc cyanide under conditions capable of forming said tigogenyl. beta. -O-cellobioside heptaalkanoate. The analogous preparations of hecogenin. beta. -O-cellobioside heptaalkanoate 11-ketotigogenin. beta. -O-cellobioside heptaalkanoate, and diosgenin. beta. -O-cellobioside heptaalkanoate are also disclosed. The process provides both high. beta. -anomeric selectivity and high yields.